These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25536903)

  • 1. Adult care for Duchenne muscular dystrophy in the UK.
    Rodger S; Woods KL; Bladen CL; Stringer A; Vry J; Gramsch K; Kirschner J; Thompson R; Bushby K; Lochmüller H
    J Neurol; 2015 Mar; 262(3):629-41. PubMed ID: 25536903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Cross-Sectional Survey of Current Care Practices for Duchenne Muscular Dystrophy Reveals Regional and Age-Dependent Differences.
    Vry J; Gramsch K; Rodger S; Thompson R; Steffensen BF; Rahbek J; Doerken S; Tassoni A; Beytía ML; Guergueltcheva V; Chamova T; Tournev I; Kostera-Pruszczyk A; Kaminska A; Lusakowska A; Mrazova L; Pavlovska L; Strenkova J; Vondráček P; Garami M; Karcagi V; Herczegfalvi Á; Bushby K; Lochmüller H; Kirschner J
    J Neuromuscul Dis; 2016 Nov; 3(4):517-527. PubMed ID: 27911335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of care practices for young boys with Duchenne muscular dystrophy between Japan and European countries: Implications of early diagnosis.
    Takeuchi F; Komaki H; Yamagata Z; Maruo K; Rodger S; Kirschner J; Kubota T; Kimura E; Takeda S; Gramsch K; Vry J; Bushby K; Lochmüller H; Wada K; Nakamura H
    Neuromuscul Disord; 2017 Oct; 27(10):894-904. PubMed ID: 28807665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Health-Related Quality of Life in boys with Duchenne muscular dystrophy from six European countries.
    Otto C; Steffensen BF; Højberg AL; Barkmann C; Rahbek J; Ravens-Sieberer U; Mahoney A; Vry J; Gramsch K; Thompson R; Rodger S; Bushby K; Lochmüller H; Kirschner J
    J Neurol; 2017 Apr; 264(4):709-723. PubMed ID: 28175989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance to Care Guidelines for Duchenne Muscular Dystrophy.
    Landfeldt E; Lindgren P; Bell CF; Schmitt C; Guglieri M; Straub V; Lochmüller H; Bushby K
    J Neuromuscul Dis; 2015; 2(1):63-72. PubMed ID: 26870664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standards of care for Duchenne muscular dystrophy: brief TREAT-NMD recommendations.
    Sejerson T; Bushby K;
    Adv Exp Med Biol; 2009; 652():13-21. PubMed ID: 20225016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database.
    Koeks Z; Bladen CL; Salgado D; van Zwet E; Pogoryelova O; McMacken G; Monges S; Foncuberta ME; Kekou K; Kosma K; Dawkins H; Lamont L; Bellgard MI; Roy AJ; Chamova T; Guergueltcheva V; Chan S; Korngut L; Campbell C; Dai Y; Wang J; Barišić N; Brabec P; Lähdetie J; Walter MC; Schreiber-Katz O; Karcagi V; Garami M; Herczegfalvi A; Viswanathan V; Bayat F; Buccella F; Ferlini A; Kimura E; van den Bergen JC; Rodrigues M; Roxburgh R; Lusakowska A; Kostera-Pruszczyk A; Santos R; Neagu E; Artemieva S; Rasic VM; Vojinovic D; Posada M; Bloetzer C; Klein A; Díaz-Manera J; Gallardo E; Karaduman AA; Oznur T; Topaloğlu H; El Sherif R; Stringer A; Shatillo AV; Martin AS; Peay HL; Kirschner J; Flanigan KM; Straub V; Bushby K; Béroud C; Verschuuren JJ; Lochmüller H
    J Neuromuscul Dis; 2017; 4(4):293-306. PubMed ID: 29125504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory Care Received by Individuals With Duchenne Muscular Dystrophy From 2000 to 2011.
    Andrews JG; Soim A; Pandya S; Westfield CP; Ciafaloni E; Fox DJ; Birnkrant DJ; Cunniff CM; Sheehan DW;
    Respir Care; 2016 Oct; 61(10):1349-59. PubMed ID: 27507176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DISEASE BURDEN OP DUCHENNE MUSCULAR DYSTROPHY PATIENTS AND THEIR CAREGIVERS].
    Péntek M; Herczegfalvi Á; Molnár MJ; Szőnyi LP; Kosztolányi G; Pfliegler G; Melegh B; Boncz I; Brodszky V; Baji P; Szegedi M; Pogány G; Gulácsi L
    Ideggyogy Sz; 2016 Mar; 69(5-6):183-93. PubMed ID: 27468608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tasks and interfaces in primary and specialized palliative care for Duchenne muscular dystrophy - A patients' perspective.
    Janisch M; Boehme K; Thiele S; Bock A; Kirschner J; Schara U; Walter MC; Nolte-Buchholtz S; von der Hagen M
    Neuromuscul Disord; 2020 Dec; 30(12):975-985. PubMed ID: 33214012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swiss physicians' practices of long-term mechanical ventilatory support of patients with Duchenne Muscular Dystrophy.
    Ramelli GP; Hammer J
    Swiss Med Wkly; 2005 Oct; 135(39-40):599-604. PubMed ID: 16333772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Death in Adults With Duchenne Muscular Dystrophy-Associated Cardiomyopathy.
    Cheeran D; Khan S; Khera R; Bhatt A; Garg S; Grodin JL; Morlend R; Araj FG; Amin AA; Thibodeau JT; Das S; Drazner MH; Mammen PPA
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health profile of a cohort of adults with Duchenne muscular dystrophy.
    Pandya S; James KA; Westfield C; Thomas S; Fox DJ; Ciafaloni E; Moxley RT
    Muscle Nerve; 2018 Aug; 58(2):219-223. PubMed ID: 29543994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
    Thongsing A; Likasitwattanakul S; Sanmaneechai O
    Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition from Childhood to Adulthood in Patients with Duchenne Muscular Dystrophy.
    Wasilewska E; Małgorzewicz S; Sobierajska-Rek A; Jabłońska-Brudło J; Górska L; Śledzińska K; Bautembach-Minkowska J; Wierzba J
    Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32846887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids in Duchenne muscular dystrophy: major variations in practice.
    Griggs RC; Herr BE; Reha A; Elfring G; Atkinson L; Cwik V; McColl E; Tawil R; Pandya S; McDermott MP; Bushby K
    Muscle Nerve; 2013 Jul; 48(1):27-31. PubMed ID: 23483575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duchenne muscular dystrophy: Canadian paediatric neuromuscular physicians survey.
    McMillan HJ; Campbell C; Mah JK;
    Can J Neurol Sci; 2010 Mar; 37(2):195-205. PubMed ID: 20437929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care utilization and costs for children and adults with duchenne muscular dystrophy.
    Teoh LJ; Geelhoed EA; Bayley K; Leonard H; Laing NG
    Muscle Nerve; 2016 Jun; 53(6):877-84. PubMed ID: 26562484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness Analysis.
    Landfeldt E; Alfredsson L; Straub V; Lochmüller H; Bushby K; Lindgren P
    Pharmacoeconomics; 2017 Feb; 35(2):249-258. PubMed ID: 27798808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.